Cargo from tumor-expressed albumin inhibits T-cell activation and responses

Michael W. Graner, Anna Likhacheva, Jane Davis, Amy Raymond, Jared Brandenberger, Angela Romanoski, Sylvia Thompson, Emmanuel Akporiaye, Emmanuel Katsanis

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

In this study, we show that rodent albumin is expressed by and cell surface localized on at least some murine tumor cells. We have been able to purify this tumor-expressed albumin from in vivo grown tumor masses. The tumor-expressed albumin, unlike normal serum albumin purified from blood, is capable of inhibiting T-cell activation, proliferation, and function in both in vitro and in vivo settings. Tumor-expressed albumin does not appear to affect antigen processing or presentation by professional antigen-presenting cells. The activity appears to lie in relatively small, lipid-like moieties that are presumably cargo for tumor-expressed albumin, and that activity can be removed from the albumin by lipid removal or treatment with lipase. Thus, we herein report of a novel form of tumor-induced immune suppression attributable to lipid-like entities, cloaked by albumin produced by tumors.

Original languageEnglish (US)
Pages (from-to)8085-8092
Number of pages8
JournalCancer Research
Volume64
Issue number21
DOIs
StatePublished - Nov 1 2004

Fingerprint

Albumins
T-Lymphocytes
Neoplasms
Antigen Presentation
Lipids
Antigen-Presenting Cells
Lipase
Serum Albumin
Rodentia
Cell Proliferation

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Graner, M. W., Likhacheva, A., Davis, J., Raymond, A., Brandenberger, J., Romanoski, A., ... Katsanis, E. (2004). Cargo from tumor-expressed albumin inhibits T-cell activation and responses. Cancer Research, 64(21), 8085-8092. https://doi.org/10.1158/0008-5472.CAN-04-1871

Cargo from tumor-expressed albumin inhibits T-cell activation and responses. / Graner, Michael W.; Likhacheva, Anna; Davis, Jane; Raymond, Amy; Brandenberger, Jared; Romanoski, Angela; Thompson, Sylvia; Akporiaye, Emmanuel; Katsanis, Emmanuel.

In: Cancer Research, Vol. 64, No. 21, 01.11.2004, p. 8085-8092.

Research output: Contribution to journalArticle

Graner, MW, Likhacheva, A, Davis, J, Raymond, A, Brandenberger, J, Romanoski, A, Thompson, S, Akporiaye, E & Katsanis, E 2004, 'Cargo from tumor-expressed albumin inhibits T-cell activation and responses', Cancer Research, vol. 64, no. 21, pp. 8085-8092. https://doi.org/10.1158/0008-5472.CAN-04-1871
Graner MW, Likhacheva A, Davis J, Raymond A, Brandenberger J, Romanoski A et al. Cargo from tumor-expressed albumin inhibits T-cell activation and responses. Cancer Research. 2004 Nov 1;64(21):8085-8092. https://doi.org/10.1158/0008-5472.CAN-04-1871
Graner, Michael W. ; Likhacheva, Anna ; Davis, Jane ; Raymond, Amy ; Brandenberger, Jared ; Romanoski, Angela ; Thompson, Sylvia ; Akporiaye, Emmanuel ; Katsanis, Emmanuel. / Cargo from tumor-expressed albumin inhibits T-cell activation and responses. In: Cancer Research. 2004 ; Vol. 64, No. 21. pp. 8085-8092.
@article{bb6daae3130148dda74f0a3621691304,
title = "Cargo from tumor-expressed albumin inhibits T-cell activation and responses",
abstract = "In this study, we show that rodent albumin is expressed by and cell surface localized on at least some murine tumor cells. We have been able to purify this tumor-expressed albumin from in vivo grown tumor masses. The tumor-expressed albumin, unlike normal serum albumin purified from blood, is capable of inhibiting T-cell activation, proliferation, and function in both in vitro and in vivo settings. Tumor-expressed albumin does not appear to affect antigen processing or presentation by professional antigen-presenting cells. The activity appears to lie in relatively small, lipid-like moieties that are presumably cargo for tumor-expressed albumin, and that activity can be removed from the albumin by lipid removal or treatment with lipase. Thus, we herein report of a novel form of tumor-induced immune suppression attributable to lipid-like entities, cloaked by albumin produced by tumors.",
author = "Graner, {Michael W.} and Anna Likhacheva and Jane Davis and Amy Raymond and Jared Brandenberger and Angela Romanoski and Sylvia Thompson and Emmanuel Akporiaye and Emmanuel Katsanis",
year = "2004",
month = "11",
day = "1",
doi = "10.1158/0008-5472.CAN-04-1871",
language = "English (US)",
volume = "64",
pages = "8085--8092",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "21",

}

TY - JOUR

T1 - Cargo from tumor-expressed albumin inhibits T-cell activation and responses

AU - Graner, Michael W.

AU - Likhacheva, Anna

AU - Davis, Jane

AU - Raymond, Amy

AU - Brandenberger, Jared

AU - Romanoski, Angela

AU - Thompson, Sylvia

AU - Akporiaye, Emmanuel

AU - Katsanis, Emmanuel

PY - 2004/11/1

Y1 - 2004/11/1

N2 - In this study, we show that rodent albumin is expressed by and cell surface localized on at least some murine tumor cells. We have been able to purify this tumor-expressed albumin from in vivo grown tumor masses. The tumor-expressed albumin, unlike normal serum albumin purified from blood, is capable of inhibiting T-cell activation, proliferation, and function in both in vitro and in vivo settings. Tumor-expressed albumin does not appear to affect antigen processing or presentation by professional antigen-presenting cells. The activity appears to lie in relatively small, lipid-like moieties that are presumably cargo for tumor-expressed albumin, and that activity can be removed from the albumin by lipid removal or treatment with lipase. Thus, we herein report of a novel form of tumor-induced immune suppression attributable to lipid-like entities, cloaked by albumin produced by tumors.

AB - In this study, we show that rodent albumin is expressed by and cell surface localized on at least some murine tumor cells. We have been able to purify this tumor-expressed albumin from in vivo grown tumor masses. The tumor-expressed albumin, unlike normal serum albumin purified from blood, is capable of inhibiting T-cell activation, proliferation, and function in both in vitro and in vivo settings. Tumor-expressed albumin does not appear to affect antigen processing or presentation by professional antigen-presenting cells. The activity appears to lie in relatively small, lipid-like moieties that are presumably cargo for tumor-expressed albumin, and that activity can be removed from the albumin by lipid removal or treatment with lipase. Thus, we herein report of a novel form of tumor-induced immune suppression attributable to lipid-like entities, cloaked by albumin produced by tumors.

UR - http://www.scopus.com/inward/record.url?scp=7444269661&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7444269661&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-04-1871

DO - 10.1158/0008-5472.CAN-04-1871

M3 - Article

C2 - 15520220

AN - SCOPUS:7444269661

VL - 64

SP - 8085

EP - 8092

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 21

ER -